학술논문
An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM)
Document Type
Article
Author
Source
In Annals of Oncology May 2005 16(5):825-833
Subject
Language
ISSN
0923-7534